Arrowhead Research | ARWR - Ricavi Di Vendita





I Saldi Cambiamento Data
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 75.23M 1.49M 2026-06
Heron Therapeutics USD 40.59M 2.38M 2025-12
Incyte USD 1.56B 110M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
Ligand Pharmaceuticals USD 78.75M 4.95M 2026-09
Merck USD 18.1B 1.5B 2026-09
Moderna USD 1.31M 98.69M 2026-09
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novartis USD 14.52B 112M 2026-09
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
TG Therapeutics USD 259.94M 19.6M 2026-09
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09
Xencor USD 116.52M 65.3M 2026-09